<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01440972</url>
  </required_header>
  <id_info>
    <org_study_id>201109738</org_study_id>
    <nct_id>NCT01440972</nct_id>
  </id_info>
  <brief_title>Assessment of Efficacy of Low Intensity Resistance Training in Women at Risk for Symptomatic Knee Osteoarthritis</brief_title>
  <acronym>PBFR2</acronym>
  <official_title>Assessment of Efficacy of Low Intensity Resistance Training in Women at Risk for Symptomatic Knee Osteoarthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Iowa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The American Geriatrics Society</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Iowa</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to asses the efficacy of a 4 week low-intensity resistance
      training program with concurrent application of partial blood flow restriction (PBFR) to the
      exercising limbs to improve quadriceps strength and size, leg muscle power, and mobility in
      women at risk for developing symptomatic knee osteoarthritis. The primary outcome will be
      change in isotonic double leg-press 1 repetition maximum (1RM) strength. The investigators
      will test the following hypotheses. In comparison with low-intensity resistance training
      without use of PBFR, a four-week low-intensity resistance-training program with PBFR will:

      Primary Hypothesis: Increase (a) double leg-press 1RM strength and (b) isokinetic knee
      extensor strength

      Secondary Hypotheses:

        1. Increase quadriceps muscle volume assessed by MRI

        2. Increase lower limb muscle power on (a) double leg-press at 40% 1RM and (b) a timed
           stair climb

        3. Not adversely effect knee pain or quality of life assessed by the Knee injury and
           Osteoarthritis Outcome Score (KOOS) questionnaire
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2011</start_date>
  <completion_date type="Actual">November 2011</completion_date>
  <primary_completion_date type="Actual">November 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Isotonic Double Leg-press 1 Repetition Maximum Strength Scaled to Body Mass</measure>
    <time_frame>4 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Quadriceps Muscle Volume by Magnetic Resonance Imaging</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Lower Limb Muscle Power by Double Leg-press at 40% 1 Repetition Maximum</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Knee Injury and Osteoarthritis Outcome Score Pain Subscale</measure>
    <time_frame>4 weeks</time_frame>
    <description>KOOS consists of 5 subscales; Pain, other Symptoms, Function in daily living (ADL), Function in sport and recreation (Sport/Rec) and knee related Quality of life QOL. The last week is taken into consideration when answering the questions. Standardized answer options are given (5 Likert boxes) and each question gets a score from 0 to 4. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale. KOOS is patient-administered, the format is user friendly, and takes about 10 minutes to fill out. Only the pain sub scale was used for the reported study.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Isokinetic Knee Extensor Strength</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">45</enrollment>
  <condition>Knee Osteoarthritis</condition>
  <condition>Symptomatic Knee Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Exercise without PBFR</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>exercise with PBFR</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>partial blood flow restriction (PBFR)</intervention_name>
    <description>low intensity resistance training with partial blood flow restriction 3 times/week for 4 weeks.</description>
    <arm_group_label>exercise with PBFR</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>low intensity resistance training</intervention_name>
    <description>low intensity resistance training without partial blood flow restriction</description>
    <arm_group_label>Exercise without PBFR</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female

          -  Age 45-65

          -  BMI greater than or equal to 25 kg/m2, or a history of a knee joint injury or surgery,
             or knee symptoms (pain, aching, or stiffness) on most of the last 30 days, or knee
             osteoarthritis

        Exclusion Criteria:

          -  Resistance training at any time in the last 3 months prior to study

          -  Bilateral knee replacement

          -  Lower limb amputation

          -  Lower limb surgery in the last 6 months that affects walking ability or ability to
             exercise

          -  Back, hip or knee problems that affect walking ability or ability to exercise

          -  Unable to walk without a cane or walker

          -  Inflammatory joint or muscle disease such as rheumatoid or psoriatic arthritis or
             polymyalgia rheumatica

          -  Multiple sclerosis

          -  Known neuropathy

          -  Self-report of Diabetes

          -  Currently being treated for cancer or having untreated cancer

          -  Terminal illness (cannot be cured or adequately treated and there is a reasonable
             expectation of death in the near future)

          -  Peripheral Vascular Disease

          -  History of myocardial infarction or stroke in the last year

          -  History of deep venous thrombosis

          -  Chest pain during exercise or at rest

          -  Use of supplemental oxygen

          -  Inability to follow protocol (e.g. lack of ability to attend visits or understand
             instructions)

          -  Staff concern for subject health (such as history of dizziness/faintness or current
             restrictions on activity)

          -  Concurrent study participation (such as the MOST study)

          -  Unable to attend more than 2 days within any 1 week or unable to attend 4 or more
             sessions during the study
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Iowa</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 21, 2011</study_first_submitted>
  <study_first_submitted_qc>September 23, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 27, 2011</study_first_posted>
  <results_first_submitted>June 10, 2015</results_first_submitted>
  <results_first_submitted_qc>July 2, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 30, 2015</results_first_posted>
  <last_update_submitted>October 24, 2016</last_update_submitted>
  <last_update_submitted_qc>October 24, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 5, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Iowa</investigator_affiliation>
    <investigator_full_name>Neil A Segal</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>knee osteoarthritis</keyword>
  <keyword>symptomatic knee osteoarthritis</keyword>
  <keyword>isotonic leg-press strength</keyword>
  <keyword>isokinetic knee extensor strength</keyword>
  <keyword>quadriceps volume</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Exercise Without PBFR</title>
          <description>low intensity resistance training: low intensity resistance training without partial blood flow restriction</description>
        </group>
        <group group_id="P2">
          <title>Exercise With PBFR</title>
          <description>partial blood flow restriction (PBFR): low intensity resistance training with partial blood flow restriction 3 times/week for 4 weeks.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="24"/>
                <participants group_id="P2" count="21"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Exercise Without PBFR</title>
          <description>low intensity resistance training: low intensity resistance training without partial blood flow restriction</description>
        </group>
        <group group_id="B2">
          <title>Exercise With PBFR</title>
          <description>partial blood flow restriction (PBFR): low intensity resistance training with partial blood flow restriction 3 times/week for 4 weeks.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="21"/>
            <count group_id="B2" value="19"/>
            <count group_id="B3" value="40"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="54.6" spread="6.9"/>
                    <measurement group_id="B2" value="56.1" spread="5.9"/>
                    <measurement group_id="B3" value="55.4" spread="6.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Isotonic Double Leg-press 1 Repetition Maximum Strength Scaled to Body Mass</title>
        <time_frame>4 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Exercise Without PBFR</title>
            <description>low intensity resistance training: low intensity resistance training without partial blood flow restriction</description>
          </group>
          <group group_id="O2">
            <title>Exercise With PBFR</title>
            <description>partial blood flow restriction (PBFR): low intensity resistance training with partial blood flow restriction 3 times/week for 4 weeks.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Isotonic Double Leg-press 1 Repetition Maximum Strength Scaled to Body Mass</title>
          <units>kg per kg body mass</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="0.3"/>
                    <measurement group_id="O2" value="0.4" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Quadriceps Muscle Volume by Magnetic Resonance Imaging</title>
        <time_frame>4 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Exercise Without PBFR</title>
            <description>low intensity resistance training: low intensity resistance training without partial blood flow restriction</description>
          </group>
          <group group_id="O2">
            <title>Exercise With PBFR</title>
            <description>partial blood flow restriction (PBFR): low intensity resistance training with partial blood flow restriction 3 times/week for 4 weeks.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Quadriceps Muscle Volume by Magnetic Resonance Imaging</title>
          <units>Percent change</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread=".73"/>
                    <measurement group_id="O2" value="1.3" spread="0.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Lower Limb Muscle Power by Double Leg-press at 40% 1 Repetition Maximum</title>
        <time_frame>4 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Exercise Without PBFR</title>
            <description>low intensity resistance training: low intensity resistance training without partial blood flow restriction</description>
          </group>
          <group group_id="O2">
            <title>Exercise With PBFR</title>
            <description>partial blood flow restriction (PBFR): low intensity resistance training with partial blood flow restriction 3 times/week for 4 weeks.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Lower Limb Muscle Power by Double Leg-press at 40% 1 Repetition Maximum</title>
          <units>Watts</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.42" spread=".26"/>
                    <measurement group_id="O2" value=".62" spread=".27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Knee Injury and Osteoarthritis Outcome Score Pain Subscale</title>
        <description>KOOS consists of 5 subscales; Pain, other Symptoms, Function in daily living (ADL), Function in sport and recreation (Sport/Rec) and knee related Quality of life QOL. The last week is taken into consideration when answering the questions. Standardized answer options are given (5 Likert boxes) and each question gets a score from 0 to 4. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale. KOOS is patient-administered, the format is user friendly, and takes about 10 minutes to fill out. Only the pain sub scale was used for the reported study.</description>
        <time_frame>4 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Exercise Without PBFR</title>
            <description>low intensity resistance training: low intensity resistance training without partial blood flow restriction</description>
          </group>
          <group group_id="O2">
            <title>Exercise With PBFR</title>
            <description>partial blood flow restriction (PBFR): low intensity resistance training with partial blood flow restriction 3 times/week for 4 weeks.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Knee Injury and Osteoarthritis Outcome Score Pain Subscale</title>
          <description>KOOS consists of 5 subscales; Pain, other Symptoms, Function in daily living (ADL), Function in sport and recreation (Sport/Rec) and knee related Quality of life QOL. The last week is taken into consideration when answering the questions. Standardized answer options are given (5 Likert boxes) and each question gets a score from 0 to 4. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale. KOOS is patient-administered, the format is user friendly, and takes about 10 minutes to fill out. Only the pain sub scale was used for the reported study.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8" spread="2.7"/>
                    <measurement group_id="O2" value="2.0" spread="2.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Isokinetic Knee Extensor Strength</title>
        <time_frame>4 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Exercise Without PBFR</title>
            <description>low intensity resistance training: low intensity resistance training without partial blood flow restriction</description>
          </group>
          <group group_id="O2">
            <title>Exercise With PBFR</title>
            <description>partial blood flow restriction (PBFR): low intensity resistance training with partial blood flow restriction 3 times/week for 4 weeks.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Isokinetic Knee Extensor Strength</title>
          <units>Nm/kg</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.05" spread="0.03"/>
                    <measurement group_id="O2" value=".07" spread=".03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Exercise Without PBFR</title>
          <description>low intensity resistance training: low intensity resistance training without partial blood flow restriction</description>
        </group>
        <group group_id="E2">
          <title>Exercise With PBFR</title>
          <description>partial blood flow restriction (PBFR): low intensity resistance training with partial blood flow restriction 3 times/week for 4 weeks.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Neil Segal</name_or_title>
      <organization>University of Iowa</organization>
      <phone>3193358204</phone>
      <email>segal-research@uiowa.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

